CERNOSTICS
Cernostics is a life science company developing new molecular diagnostic tests for the fight against cancer. Most current diagnostic approaches offer a limited view of cancer because they fail to evaluate the tumor as a system composed of multiple cell types, not merely tumor cells. Its patent-protected technology platform, TissueCypher, uniquely analyzes whole slide digital images with multiplexed fluorescence, providing greater information and accuracy than traditional subjective tissue diagnostics.
CERNOSTICS
Industry:
Biotechnology Health Diagnostics Life Science Medical Device
Founded:
2008-01-01
Address:
Danville, Pennsylvania, United States
Country:
United States
Website Url:
http://www.cernostics.com
Total Employee:
11+
Status:
Active
Contact:
(570)214-5123
Email Addresses:
[email protected]
Total Funding:
21.26 M USD
Technology used in webpage:
SPF Content Delivery Network Euro US Privacy User Signal Mechanism YouTube Google Analytics 4 Unified Layer LinkedIn Insights CPanel Google Conversion Linker
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Current Advisors List
Current Employees Featured
Founder
Investors List
Illumina Ventures
Illumina Ventures investment in Series A - Cernostics
UPMC
UPMC investment in Venture Round - Cernostics
Novitas Capital
Novitas Capital investment in Venture Round - Cernostics
Ben Franklin Technology Partners of Northeastern Pennsylvania
Ben Franklin Technology Partners of Northeastern Pennsylvania investment in Venture Round - Cernostics
Ben Franklin Technology Partners of Northeastern Pennsylvania
Ben Franklin Technology Partners of Northeastern Pennsylvania investment in Venture Round - Cernostics
Geisinger Health System
Geisinger Health System investment in Series B - Cernostics
Pittsburgh Life Sciences Greenhouse
Pittsburgh Life Sciences Greenhouse investment in Series B - Cernostics
Novitas Capital
Novitas Capital investment in Series B - Cernostics
Novitas Capital
Novitas Capital investment in Venture Round - Cernostics
Ben Franklin Technology Partners of Northeastern Pennsylvania
Ben Franklin Technology Partners of Northeastern Pennsylvania investment in Debt Financing - Cernostics
Official Site Inspections
http://www.cernostics.com
- Host name: a3ef2d3a3279c65d0.awsglobalaccelerator.com
- IP address: 76.223.88.164
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Cernostics"
Cernostics: Contact Details and Business Profile - RocketReach
Cernostics takes a tissue systems biology approach to anatomic pathology. Its patent-protected technology platform, TissueCypher, uniquely analyzes whole slide digital images with …See details»
Castle Biosciences Completes Acquisition of Cernostics
Dec 6, 2021 Cernostics specializes in spatial biology and artificial intelligence-driven image analysis of tissue biopsies. Its TissueCypher® Barrett’s Esophagus Assay is the first precision …See details»
Cernostics - LinkedIn
Cernostics is now part of the Castle Biosciences family, so we won’t be posting here anymore. Please join us on our new channel, Castle Biosciences, Inc.!See details»
Cernostics Company Profile - Office Locations, Competitors ... - Craft
Cernostics is a diagnostics company focused on delivering next-generation cancer diagnostics and prognostics through a unique approach to tissue analysis. Cernostics takes a tissue …See details»
Cernostics Company Profile 2024: Valuation, Investors …
Cernostics General Information Description. Developer of spatial biology and AI-driven image analytics device intended to provide valuable insight to pharma clients on the pathophysiology of the disease, biomarker discovery and …See details»
Castle Biosciences Completes Acquisition of Cernostics
Dec 6, 2021 Castle Biosciences Completes Acquisition of Cernostics TissueCypher® Barrett’s Esophagus test adds approximately $1 billion to Castle’s estimated U.S. TAM and drives expansion into ...See details»
Castle Biosciences to Acquire Cernostics - Business Wire
Oct 19, 2021 Cernostics applies spatial biology and biologically-aware AI and machine learning to tissue diagnostics, delivering precision diagnostic testing to patients and gastroenterologists.See details»
Pittsburgh Life Sciences Greenhouse Proudly …
Oct 25, 2021 Cernostics' executive management team and other staff who are based in Pittsburgh are expected to stay with the company, ... is a comprehensive life sciences economic development organization.See details»
Pittsburgh Life Sciences Greenhouse Proudly …
PITTSBURGH, Oct. 25, 2021 /PRNewswire/ -- Pittsburgh Life Science Greenhouse (PLSG) is proud to share that one of its portfolio companies, Cernostics, Inc., is being acquired by Castle Biosciences ...See details»
Cernostics - Funding, Financials, Valuation & Investors - Crunchbase
Cernostics is funded by 7 investors. Illumina Ventures and UPMC are the most recent investors. Cernostics has a post-money valuation in the range of $10M to $50M as of Mar 22, 2018, …See details»
Cernostics, Inc. Company Profile | Pittsburgh, PA | Competitors ...
Find company research, competitor information, contact details & financial data for Cernostics, Inc. of Pittsburgh, PA. Get the latest business insights from Dun & Bradstreet.See details»
Cernostics - Contacts, Employees, Board Members, Advisors
Cernostics is a life science company developing new molecular diagnostic tests to treat cancer.See details»
Biotech firm Cernostics is taken public via acquisition, with capital ...
Oct 22, 2021 As momentum builds for Pittsburgh life sciences, a new acquisition will take a local biotech company public.. Earlier this week, Castle Biosciences announced a $30 million …See details»
Here's what Cernostics' acquisition means for Pittsburgh and the ...
Oct 20, 2021 Cernostics has a long history in Pittsburgh, founded in 2008 as a spinoff of Cellumen Inc. to use artificial intelligence and predictive analysis for pathology and tissue …See details»
Pittsburgh Life Sciences Greenhouse Proudly Announces Portfolio …
Cernostics’ executive management team and other staff who are based in Pittsburgh are expected to ... is a comprehensive life sciences economic development organization. We are …See details»
Castle Biosciences taps into Cernostics' GI cancer test franchise …
Oct 19, 2021 Cernostics, previously backed by Illumina Ventures, presented validation data for its TissueCypher test this year, taken from a study funded by the National Institutes of Health …See details»
Castle Biosciences Completes Acquisition of Cernostics
Dec 6, 2021 Castle Biosciences, Inc., a company applying innovative diagnostics to transform disease management and improve patient outcomes, today announced it has completed its …See details»
Cernostics Announces Groundbreaking Data Demonstrating …
Mar 3, 2020 Cernostics' mission is to quantify the tissue system complexity, providing physicians and patients with individualized, actionable information to improve outcomes and reduce the …See details»
Cernostics Announces Blinded, Independent Validation of …
Jun 25, 2020 Cernostics' mission is to quantify the tissue system complexity, providing physicians and patients with individualized, actionable information to improve outcomes and …See details»